Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers.
作者信息
Kelloff Gary J, O'Shaughnessy Joyce A, Gordon Gary B, Hawk Ernest T, Sigman Caroline C
机构信息
National Cancer Institute, Division of Cancer Treatment and Diagnosis, Biomedical Imaging Program, Bethesda, Maryland 20892, USA.
出版信息
Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):593-6.
PMID:12869396
Abstract
摘要
Zotero 插件